Health
J&J starts human study of COVID-19 vaccine after promising monkey data – Yahoo Finance
When exposed to the virus, six out of six animals who got the vaccine candidate were completely protected from lung disease and five out of six were protected from infection as measured by the presence of virus in nasal swabs, according to the study published…
By Julie Steenhuysen
(Reuters) – Johnson & Johnson <JNJ.N> on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.
When exposed to the virus, six out of six animals who got the vaccine candidate were completely protected from lung disease and five out of six were protected from infection as measured by the presence of virus in na…
-
Noosa News18 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business23 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General24 hours agoRush to buy homes before rate cuts send prices soaring
-
Business20 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025